Editas Medicine
EDIT
$5.53
Share price
6.14%
Change (1 day)
-33.37%
Change (1 year)
P/S ratio for Editas Medicine (EDIT)
P/S ratio as of May 2024 (TTM): 5.48
According to Editas Medicine 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.48421. At the end of 2023 the company had a P/S ratio of 10.6.
P/S ratio history for Editas Medicine from 2016 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 10.6 | -65.78% |
| 2022 | 30.9 | -56.47% |
| 2021 | 71.1 | 47.6% |
| 2020 | 48.2 | -38.56% |
| 2019 | 78.4 | 125.7% |
| 2018 | 34.7 | -63.16% |
| 2017 | 94.3 | -4.07% |
| 2016 | 98.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 50.4 | 818.37% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | 217.37% | 🇬🇧 UK |
 Novavax NVAX | 0.8739 | -84.07% | 🇺🇸 USA |
 Novocure
NVCR | 2.59 | -52.85% | Jersey |